How about Shenzhen Kangtai Biotech’s COVID-19 vaccine?

1. The COVID-19 vaccine produced by Kangtai Biologics is an inactivated vaccine, which is of the same type and production technology route as the COVID-19 vaccines developed by Beijing Biotech, Wuhan Biotech and Beijing Sinovac Zhongwei.

2. According to the Phase I/II clinical trial data of Kangtai Biotech’s COVID-19 vaccine, the vaccine did not have serious adverse reactions of grade 3 or above, and the overall incidence of adverse reactions was not significantly different from the placebo group. It has good and security.

3. According to the clinical trial data of the new coronavirus vaccine released by Kangtai Biological, the expected effectiveness of the vaccine exceeds 90%, no serious adverse reactions above grade 3 occurred, and the neutralizing antibodies are 2.65 times higher than those of recovered patients, which is the highest in the country. Ranked No. 1 among all COVID-19 vaccine brands and No. 4 globally.

4. The new coronavirus vaccine produced by Kangtai Biological Sciences is named KCONVAC. Currently, it has launched phase III clinical trials. The previous Phase I/II clinical trial results were published on the preprint website MedRxiv on April 8 and have not yet been peer-reviewed.

5. A few days ago, Shenzhen Kangtai Biological Products Co., Ltd. issued an announcement stating that the company had recently received a notice from the vaccine research and development class of the scientific research team of the Joint Prevention and Control Mechanism of the State Council. According to the relevant provisions of Article 20 of the National Vaccine Administration Law, the new coronavirus inactivated vaccine developed by the company was recommended by the National Health Commission, and the State Food and Drug Administration organized a demonstration and approved emergency use.